NCT05786547View on ClinicalTrials.gov

V+PSF-M for Tobacco Cessation in HIV Care in India

PHASE3RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

July 22, 2026

Study Completion Date

July 22, 2026

Conditions
Human Immunodeficiency VirusSmoking CessationSmoking, Tobacco
Interventions
DRUG

Varenicline

Per package dosing, tablet taken orally

BEHAVIORAL

Positively Smoke Free Mobile (PSF-M)

Behavioral tobacco cessation intervention for people living with HIV, delivered via mobile phone

BEHAVIORAL

Standard Care

Brief cessation advice plus referral to local tobacco quitline

Trial Locations (2)

80045

RECRUITING

University of Colorado, Aurora

600113

RECRUITING

VHS Infectious Disease Medical Centre, CART Clinical Research Site, Chennai

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER